Effect of the Metabolic Syndrome and Hyperuricemia on Outcome in Patients With Coronary Artery Disease (from the Bezafibrate Infarction Prevention Study)
Authors:
- Pierre ChouraquiPCPierre Chouraqui
- 1 December 2010
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 106 (12) , 1717-1720
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)Journal of Internal Medicine, 2009
- Serum Uric Acid for Risk Stratification of Patients with Coronary Artery DiseaseCardiology, 2009
- Uric Acid and Cardiovascular RiskNew England Journal of Medicine, 2008
- Uric Acid Levels Are Associated With All-Cause and Cardiovascular Disease Mortality Independent of Systemic Inflammation in Men From the General PopulationArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Serum Uric Acid Is a Determinant of Metabolic Syndrome in a Population-Based StudyAmerican Journal of Hypertension, 2006
- Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?Circulation, 2004
- Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention StudyCirculation, 2003
- Diet, Obesity, and Cardiovascular RiskNew England Journal of Medicine, 2003
- Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP)Journal Of Hypertension, 2000
- A Metabolic Syndrome in Whites and African-Americans: The Atherosclerosis Risk in Communities baseline studyDiabetes Care, 1996